ArticleClinical ophthalmology (Auckland, N.Z.)2025

CompaRative Safety Analysis of Innovator and BioSimilar Ranibizumab in Chorioretinal Vascular Diseases - The CRsIBS Study.

Debdulal Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.